Diaceutics Management

Management criteria checks 2/4

Diaceutics' CEO is Ryan Keeling, appointed in Jan 2024, has a tenure of less than a year. total yearly compensation is £334.27K, comprised of 75.2% salary and 24.8% bonuses, including company stock and options. directly owns 3.54% of the company’s shares, worth £3.11M. The average tenure of the management team and the board of directors is 2 years and 2 years respectively.

Key information

Ryan Keeling

Chief executive officer

UK£334.3k

Total compensation

CEO salary percentage75.2%
CEO tenureless than a year
CEO ownership3.5%
Management average tenure2yrs
Board average tenure2yrs

Recent management updates

Recent updates

Diaceutics PLC's (LON:DXRX) Subdued P/S Might Signal An Opportunity

Jan 31
Diaceutics PLC's (LON:DXRX) Subdued P/S Might Signal An Opportunity

Industry Analysts Just Made A Notable Upgrade To Their Diaceutics PLC (LON:DXRX) Revenue Forecasts

Jan 28
Industry Analysts Just Made A Notable Upgrade To Their Diaceutics PLC (LON:DXRX) Revenue Forecasts

Estimating The Intrinsic Value Of Diaceutics PLC (LON:DXRX)

Jul 24
Estimating The Intrinsic Value Of Diaceutics PLC (LON:DXRX)

Would Shareholders Who Purchased Diaceutics' (LON:DXRX) Stock Year Be Happy With The Share price Today?

Feb 04
Would Shareholders Who Purchased Diaceutics' (LON:DXRX) Stock Year Be Happy With The Share price Today?

Here's Why We Don't Think Diaceutics's (LON:DXRX) Statutory Earnings Reflect Its Underlying Earnings Potential

Dec 31
Here's Why We Don't Think Diaceutics's (LON:DXRX) Statutory Earnings Reflect Its Underlying Earnings Potential

Do Insiders Own Lots Of Shares In Diaceutics PLC (LON:DXRX)?

Nov 27
Do Insiders Own Lots Of Shares In Diaceutics PLC (LON:DXRX)?

CEO Compensation Analysis

How has Ryan Keeling's remuneration changed compared to Diaceutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2023n/an/a

UK£6k

Mar 31 2023n/an/a

UK£365k

Dec 31 2022UK£334kUK£252k

UK£724k

Sep 30 2022n/an/a

UK£427k

Jun 30 2022n/an/a

UK£129k

Mar 31 2022n/an/a

UK£345k

Dec 31 2021UK£231kUK£220k

UK£561k

Sep 30 2021n/an/a

-UK£294k

Jun 30 2021n/an/a

-UK£1m

Mar 31 2021n/an/a

-UK£443k

Dec 31 2020UK£225kUK£215k

UK£263k

Sep 30 2020n/an/a

UK£2m

Jun 30 2020n/an/a

UK£3m

Mar 31 2020n/an/a

UK£2m

Dec 31 2019UK£236kUK£175k

UK£398k

Sep 30 2019n/an/a

UK£124k

Jun 30 2019n/an/a

-UK£151k

Mar 31 2019n/an/a

UK£241k

Dec 31 2018UK£78kn/a

UK£632k

Compensation vs Market: Ryan's total compensation ($USD422.42K) is about average for companies of similar size in the UK market ($USD344.62K).

Compensation vs Earnings: Ryan's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


CEO

Ryan Keeling (41 yo)

less than a year

Tenure

UK£334,266

Compensation

Mr. Ryan Keeling serves as Executive Director of Diaceutics PLC, he joined the company in 2006 and serves as Chief Executive Officer since 2024 and is responsible for the innovation strategy for the Diaceu...


Leadership Team

NamePositionTenureCompensationOwnership
Ryan Keeling
CEO & Directorless than a yearUK£334.27k3.54%
£ 3.1m
Peter Keeling
Founder & Executive Directorno dataUK£363.24k20.43%
£ 17.9m
Nicholas Roberts
CFO & Director2yrsUK£180.37k0.049%
£ 43.2k
Julie Browne
Chief Operating Officer2yrsno datano data
Gillian Shaw
General Counsel2.2yrsno datano data
Norma Thompson
Global Head of Human Resources3.5yrsno datano data
Jordan Clark
Chief Commercial Officer2.2yrsno data0.83%
£ 732.2k
Susanne Munksted
Chief Precision Medicine Officer5.2yrsno datano data
Jillian Beggs
Chief Commercial Officer1.2yrsno datano data
Marieke Hoefsmit
Senior Director & Head of Data Delivery Netherlands2yrsno datano data
Bethany Slifko
Head of Knowledge & Insight Team US2yrsno datano data
Sally Craig
Company Secretary3.5yrsno datano data

2.0yrs

Average Tenure

41yo

Average Age

Experienced Management: DXRX's management team is considered experienced (2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ryan Keeling
CEO & Directorno dataUK£334.27k3.54%
£ 3.1m
Peter Keeling
Founder & Executive Directorno dataUK£363.24k20.43%
£ 17.9m
Nicholas Roberts
CFO & Director2yrsUK£180.37k0.049%
£ 43.2k
Graham Paterson
Independent Non-Executive Directorless than a yearno data0.040%
£ 34.9k
Kenneth Bloom
Member of Advisory Boardno datano datano data
Michael Wort
Independent Non-Executive Directorno dataUK£30.00k0.17%
£ 150.5k
Deborah Davis
Independent Non-Executive Chair3.2yrsUK£70.00k0.10%
£ 89.4k
Keith Kerr
Member of Advisory Boardno datano datano data
Markus Eckstein
Member of Advisory Boardno datano datano data

2.0yrs

Average Tenure

60yo

Average Age

Experienced Board: DXRX's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.